Seizures Global Market Report 2025

Description

Seizures are sudden, uncontrolled electrical activities in the brain that can cause changes in movement, behavior, sensation, or awareness. They result from abnormal neuronal activity and can be triggered by conditions such as epilepsy, head injuries, infections, or other medical issues.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary drug types used to treat seizures are first-generation, second-generation, and third-generation anti-epileptics. First-generation anti-epileptic drugs (AEDs) are the initial class of medications developed for epilepsy treatment. These drugs can be administered through various routes, including oral, parenteral, and topical methods. They are distributed through multiple channels, such as hospital pharmacies, independent pharmacies, and online pharmacies, and are utilized by several end-users, including hospitals, clinics, ambulatory surgical centers, homecare settings, and others.

The seizures market research report is one of a series of new reports from The Business Research Company that provides seizures market statistics, including the seizures industry global market size, regional shares, competitors with the seizures market share, detailed seizures market segments, market trends, and opportunities, and any further data you may need to thrive in the seizures industry. This seizures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The seizures market size has grown strongly in recent years. It will grow from$3.20 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to the rising prevalence of epilepsy and seizure disorders, greater awareness and higher diagnosis rates, expanding research and development efforts for neurological conditions, increased government and non-profit initiatives aimed at epilepsy awareness, and the growing geriatric population.

The seizures market size is expected to see strong growth in the next few years. It will grow to$5.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to the expanding geriatric population vulnerable to neurological disorders, increased investments in R&D for seizure therapeutics, rising global healthcare expenditure, growing demand for epilepsy medications, and a higher incidence of seizure disorders. Key trends during this period include advancements in seizure detection and monitoring devices, progress in drug approvals and reimbursement processes, breakthroughs in genetic research for personalized seizure treatments, the adoption of digital health solutions for remote monitoring, and ongoing innovations in epilepsy medications.

The increasing prevalence of traumatic brain injuries (TBI) is expected to drive significant growth in the seizures market. TBIs result from external forces, such as blows, jolts, or penetrating injuries to the head, and the rise in road accidents-due to high-speed collisions and distracted driving-has contributed to more severe head injuries. Seizures often serve as an early indicator of TBIs, helping doctors diagnose and manage brain damage more effectively. For example, in October 2023, a report from the South Dakota Department of Health (SDDOH) indicated that in 2022, South Dakota had the 9th highest age-adjusted TBI-related death rate in the U.S. at 26.4 per 100,000. Additionally, the American Association of Neurological Surgeons estimates that between 1.7 million and 3.8 million TBIs occur annually in the U.S. This rising prevalence of traumatic brain injuries is driving the growth of the seizures market.

Leading companies in the seizures market are focusing on innovative treatments such as buccal films to improve accessibility and patient adherence. Buccal films are thin, dissolvable strips that are administered by placing them on the inner cheek (buccal mucosa), where the drug is absorbed directly into the bloodstream. For instance, in December 2024, U.S.-based Aquestive Therapeutics Inc. received U.S. FDA approval for orphan drug exclusivity for Libervant (diazepam) buccal film. This drug is intended for pediatric patients aged two to five with seizure clusters. Libervant offers a non-invasive, easy-to-administer alternative to traditional diazepam delivery methods, ensuring faster absorption through the buccal mucosa. As the first and only orally administered diazepam film approved for this age group, Libervant aims to improve convenience for caregivers and enhance patient compliance. This approval further strengthens Aquestive's position in advancing oral film-based epilepsy therapies.

In March 2022, Belgium-based UCB Pharma acquired U.S.-based Zogenix Inc. for $1.9 billion. With this acquisition, UCB aims to expand its neurology portfolio and enhance treatment options for rare epileptic disorders such as Dravet syndrome and Lennox-Gastaut syndrome. Zogenix is known for developing therapies for rare and serious central nervous system (CNS) disorders, helping UCB strengthen its presence in the epilepsy treatment market.

Major players in the seizures market are Johnson & Johnson Service Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, SK Biopharmaceuticals Co. Ltd., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc., Taro Pharmaceutical Industries Ltd., Marinus Pharmaceuticals Inc., Eton Pharmaceuticals Inc., and Sunovion Pharmaceuticals Inc.

North America was the largest region in the seizures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in seizures report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the seizures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The seizures market consists of sales of neurostimulation devices, wearable seizure detection devices, and medical cannabis products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Seizures Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on seizures market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for seizures ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The seizures market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: First Generation Anti-Epileptics; Second Generation Anti-Epileptics; Third Generation Anti-Epileptics
2) By Route Of Administration: Oral; Parenteral; Topical
3) By Distribution Channel: Hospitals Pharmacies; Independent Pharmacies; Online Pharmacies
4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Homecare Settings; Other End-Users
Subsegments:
1) By First Generation Anti-Epileptics: Phenytoin; Carbamazepine; Valproate; Phenobarbital; Primidone; Ethosuximide
2) By Second Generation Anti-Epileptics: Lamotrigine; Levetiracetam; Topiramate; Oxcarbazepine; Zonisamide; Gabapentin; Pregabalin
3) By Third Generation Anti-Epileptics: Lacosamide; Perampanel; Brivaracetam; Eslicarbazepine; Cenobamate
Companies Mentioned: Johnson & Johnson Service Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34963

1. Executive Summary

2. Seizures Market Characteristics

3. Seizures Market Trends And Strategies

4. Seizures Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Seizures Growth Analysis And Strategic Analysis Framework

5.1. Global Seizures PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Seizures Market Growth Rate Analysis
5.4. Global Seizures Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Seizures Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Seizures Total Addressable Market (TAM)

6. Seizures Market Segmentation

6.1. Global Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First Generation Anti-Epileptics
Second Generation Anti-Epileptics
Third Generation Anti-Epileptics
6.2. Global Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Topical
6.3. Global Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals Pharmacies
Independent Pharmacies
Online Pharmacies
6.4. Global Seizures Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgical Centers
Homecare Settings
Other End-Users
6.5. Global Seizures Market, Sub-Segmentation Of First Generation Anti-Epileptics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phenytoin
Carbamazepine
Valproate
Phenobarbital
Primidone
Ethosuximide
6.6. Global Seizures Market, Sub-Segmentation Of Second Generation Anti-Epileptics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lamotrigine
Levetiracetam
Topiramate
Oxcarbazepine
Zonisamide
Gabapentin
Pregabalin
6.7. Global Seizures Market, Sub-Segmentation Of Third Generation Anti-Epileptics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lacosamide
Perampanel
Brivaracetam
Eslicarbazepine
Cenobamate

7. Seizures Market Regional And Country Analysis

7.1. Global Seizures Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Seizures Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Seizures Market

8.1. Asia-Pacific Seizures Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Seizures Market

9.1. China Seizures Market Overview
9.2. China Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Seizures Market

10.1. India Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Seizures Market

11.1. Japan Seizures Market Overview
11.2. Japan Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Seizures Market

12.1. Australia Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Seizures Market

13.1. Indonesia Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Seizures Market

14.1. South Korea Seizures Market Overview
14.2. South Korea Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Seizures Market

15.1. Western Europe Seizures Market Overview
15.2. Western Europe Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Seizures Market

16.1. UK Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Seizures Market

17.1. Germany Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Seizures Market

18.1. France Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Seizures Market

19.1. Italy Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Seizures Market

20.1. Spain Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Seizures Market

21.1. Eastern Europe Seizures Market Overview
21.2. Eastern Europe Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Seizures Market

22.1. Russia Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Seizures Market

23.1. North America Seizures Market Overview
23.2. North America Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Seizures Market

24.1. USA Seizures Market Overview
24.2. USA Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Seizures Market

25.1. Canada Seizures Market Overview
25.2. Canada Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Seizures Market

26.1. South America Seizures Market Overview
26.2. South America Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Seizures Market

27.1. Brazil Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Seizures Market

28.1. Middle East Seizures Market Overview
28.2. Middle East Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Seizures Market

29.1. Africa Seizures Market Overview
29.2. Africa Seizures Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Seizures Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Seizures Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Seizures Market Competitive Landscape And Company Profiles

30.1. Seizures Market Competitive Landscape
30.2. Seizures Market Company Profiles
- 30.2.1. Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Seizures Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. Viatris Inc.
31.3. Teva Pharmaceutical Industries Ltd.
31.4. Bausch Health Companies Inc.
31.5. UCB S.A.
31.6. Eisai Co. Ltd.
31.7. H. Lundbeck A/S
31.8. Zydus Lifesciences Limited
31.9. SK Biopharmaceuticals Co. Ltd.
31.10. Neurocrine Biosciences Inc.
31.11. Supernus Pharmaceuticals Inc.
31.12. Taro Pharmaceutical Industries Ltd.
31.13. Marinus Pharmaceuticals Inc.
31.14. Eton Pharmaceuticals Inc.
31.15. Sunovion Pharmaceuticals Inc.

32. Global Seizures Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Seizures Market

34. Recent Developments In The Seizures Market

35. Seizures Market High Potential Countries, Segments and Strategies

35.1 Seizures Market In 2029 - Countries Offering Most New Opportunities
35.2 Seizures Market In 2029 - Segments Offering Most New Opportunities
35.3 Seizures Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r34963_Seizures_GMR_2025